Evidence map›Paper›PMID 36961842›Full record

ArticlePloS one2023

HIV retesting for pregnant and breastfeeding women across maternal child health services in Nampula, Mozambique.

Chloe A Teasdale, Michelle Choy, Fatima Tsiouris, Eduarda Pimentel De Gusmao, Etelvino C P Banqueiro, Aleny Couto, Kwalila Tibana, Nicole Flowers, Marilena Urso, Mirriah Vitale and 1 more

Erratum issuedFull text read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Chloe A TeasdaleDepartment of Epidemiology and Biostatistics, CUNY Graduate School of Public Health and Health Policy, New York, NY, United States of America.ORCID 0000-0001-9165-8972
Michelle ChoyICAP at Columbia University, Mailman School of Public Health, Columbia University, New York, NY, United States of America.
Fatima TsiourisICAP at Columbia University, Mailman School of Public Health, Columbia University, New York, NY, United States of America.ORCID 0000-0002-4403-2173
Eduarda Pimentel De GusmaoICAP at Columbia University, Mailman School of Public Health, Columbia University, New York, NY, United States of America.
Etelvino C P BanqueiroICAP at Columbia University, Mailman School of Public Health, Columbia University, New York, NY, United States of America.
Aleny CoutoMinistério da Saúde de Moçambique, Maputo, Mozambique.
Kwalila TibanaMinistério da Saúde de Moçambique, Maputo, Mozambique.
Nicole FlowersUS Centers for Disease Control and Prevention, Atlanta, GA, United States of America.ORCID 0000-0003-1377-5983
Marilena UrsoUS Centers for Disease Control and Prevention, Maputo, Mozambique.
Mirriah VitaleICAP at Columbia University, Mailman School of Public Health, Columbia University, New York, NY, United States of America.
Elaine J AbramsDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, United States of America.

Funding

CGH CDC HHS U2G GH000994
6 · The paper itself

Abstract

backgroundRepeat HIV testing during pregnancy and breastfeeding identifies women with incident infections, those living with HIV who have been lost to care, and infants at risk for HIV infection. We report data from repeat testing for women in maternal and child health (MCH) services at 10 health facilities in Mozambique.

methodsRoutinely collected data from health facility registers are reported from April-November 2019. From antenatal care (ANC), we report numbers and proportions of women eligible for retesting; returned for care when retesting eligible; retested; and HIV-positive (HIV+) at retesting. From child welfare clinics (CWC), we report mothers retested; tested HIV-positive; HIV+ mothers linked to ART services; HIV-exposed infants (HEI) tested for HIV with polymerase chain reaction (PCR) tests; HEI testing PCR positive; PCR-positive infants linked to care.

resultsIn ANC, 28,233 pregnant women tested HIV-negative at first ANC visit, 40.7% had a follow-up visit when retesting eligible, among whom 84.8% were retested and 0.3%(N = 26) tested HIV+. In CWC, 26,503 women were tested; 0.8%(N = 212) tested HIV+ and 74.1%(N = 157) of HIV+ women were linked to care. Among 157 HEI identified in CWC, 68.4%(N = 145) received PCR testing and 19.3%(N = 28) tested positive.

conclusionIn ANC, less than half of pregnant women eligible for retesting returned for follow-up visits, and test positivity was low among women retested in ANC and CWC. In CWC, linkage to infant testing was poor and almost 20% of HEI were PCR-positive. Implementing retesting for pregnant and breastfeeding women is challenging due to high numbers of women and low testing yield.

Indexed as

HIV InfectionsMaternal-Child Health ServicesPregnancy Complications, InfectiousBreast FeedingChildFemaleHumansInfantInfectious Disease Transmission, VerticalMozambiquePregnancyPregnant PeoplePrenatal Care

Identifiers

PMID36961842
PMCPMC10038279

What OpenQuestion holds

Textfull text, public
LicenceCC0
reference markers read1
measurements read60
identifiers read6
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.